Trial intelligence / Profile preview

Posterior tibial nerve stimulation and solifenacin in patients with overactive bladder

IRCT20190618043934N25Phase 3Completed

Sponsor
Mashhad University of Medical Sciences
Start
Apr 2024
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of solifenacin in overactive bladder (OAB), sponsored by Mashhad University of Medical Sciences. Started Apr 2024; status: completed.

02

Drugs

solifenacin
03

Conditions

overactive bladder (OAB)

Beyond the preview

Go deeper on IRCT20190618043934N25.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190618043934N25.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call